Clinical Study
Different Finite Durations of Anticoagulation and Outcomes following Idiopathic Venous Thromboembolism: A Meta-Analysis
Table 2
Characteristics of included studies.
| Trial | Design | Patients | Age (mean) | %male | Tx Duration (mos) | Jadad Score | Jadad Problems |
|
Agnelli et al. [6] | RCT | 90 | — | — | 12 | 6 | Not double blind | | | 91 | — | — | 3 | | |
Agnelli et al. [7] | RCT | 134 | 67 | 55 | 12 | 6 | Not double blind | | | 133 | 68 | 61 | 3 | | |
Farraj [20] | RCT | 32 | 41 | 62 | 24 | 4 | Not double blind Withdrawals/dropouts No statistics methods | | | 32 | 42 | 56 | 6 | |
Legnani [24] et al. | Cohort | 628 | 67 | 53 | 7 | 4 | Not randomized |
Kyrle [22] et al. | Cohort | 453 | 45 | 0 | 9 | 4 | Not randomized | | | 373 | 51 | 100 | 8 | | |
Palareti et al. [19] | RCT | 385 | 59 | 55 | 13.0 | 6 | Not double blind | | | 120 | 68 | 42 | 10.8 | | |
Palareti et al. [25] | Cohort | 282 | 70 | 55 | 7.5 | 4 | Not randomized |
Schulman et al. [21] | RCT | 289 | 63 | 63 | 6 | 6 | Not double blind |
Poli et al. [23] | Cohort | 183 | 60 | 57 | 14.9 | 3 | Not randomized |
|
|